Preparation method for insulin aspart through recombinant expression by using yeast

A technology of insulin aspart and yeast, which is applied in the field of recombinant protein preparation under biotechnology, can solve the problems of high enzyme dosage and low yield, and achieve the effects of high enzyme cutting efficiency, high coupling rate and low miscutting rate

Active Publication Date: 2015-11-25
CHONGQING PEG BIO BIOTECH CO LTD
View PDF8 Cites 15 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The yield of this method is lower than 70%...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method for insulin aspart through recombinant expression by using yeast
  • Preparation method for insulin aspart through recombinant expression by using yeast
  • Preparation method for insulin aspart through recombinant expression by using yeast

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0038] Example 1. Upstream construction and screening of recombinant insulin aspart

[0039](1) Design its cDNA sequence based on the amino acid sequence of recombinant human proinsulin proaspart, and design two stop codon sequences TGA and TAA behind the sequence, and design XhoI (CTCGAG) and NtoI ( GCGGCCGC) restriction enzyme site. Entrust Dalian TAKARA Engineering Co., Ltd. to carry out the whole gene synthesis.

[0040] (2) Insert the Pro-AspcDNA synthesized by the whole gene above into the PMD18-T-Pro-Asp plasmid. PMD18-T-Pro-Asp and pPICZαA were digested with restriction enzymes respectively, and two target fragments (Pro-Asp and pPICZαA large fragments) were recovered, linked by T4 and transformed into P. PastorisX-33 host bacteria to obtain Engineering bacteria (pPICZαA-Pro-Asp / X-33).

[0041] (3) By screening highly expressed engineering bacteria and optimizing the fermentation process, recombinant proinsulin aspart was obtained.

[0042] SEQ ID NO: 1 (Insuli...

example 2

[0051] Example 2. Preparation of insulin aspart

[0052] (1) Purification to obtain proinsulin aspart and enzymatic digestion to obtain missing B30-insulin aspart: 5L of Pichia pastoris fermentation broth, centrifuged, and the supernatant was subjected to copper ion chelation chromatography and SP cation exchange chromatography to obtain aspart Proinsulin; then add 20mM Zn ion to precipitate proinsulin aspart, centrifuge, dissolve the precipitate with 100ml50mMTris, the protein content is 1g, adjust the pH to 8.8, and add lysyl endopeptidase ( Lys-C) 0.2mg, digestion at 30°C with stirring. After 16 hours, samples were taken for RP-HPLC analysis, and the enzyme digestion efficiency reached 90%, and the pH was adjusted to 5.5 for isoelectric point precipitation.

[0053] (2) Coupling of desB30-insulin aspart to obtain insulin aspart ester: take the isoelectric point precipitate desB30-insulin aspart and centrifuge, dissolve with 5ml of 10% glacial acetic acid, the protein con...

example 3

[0057] Example 3. Insulin aspart preparation process optimization

[0058] (1) Purification to obtain proinsulin aspart and enzymatic digestion to obtain DesB30-insulin aspart: Pichia pastoris fermentation broth, centrifugation, supernatant per copper ion chelation chromatography and SP cation exchange chromatography for proaspart; Then add Zn to precipitate proinsulin aspart, centrifuge, dissolve the precipitate with 300ml50mM Tris, the protein content is 2.5g, adjust the pH to 9.0, and add lysyl endopeptidase (Lys-C ) 0.25mg, digested with stirring at 37°C. After 16 hours, samples were taken for RP-HPLC analysis, and the enzyme digestion efficiency reached 95%, and the pH was adjusted to 5.0 for isoelectric point precipitation.

[0059] (2) Deletion of B30-insulin aspart coupling to obtain insulin aspart ester: Take the isoelectric point precipitate DesB30-insulin aspart and centrifuge, dissolve with 10ml 10% glacial acetic acid, the protein concentration is 100mg / ml, 1...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a preparation method for insulin aspart through recombinant expression by using yeast, and concretely relates to a preparation method for insulin aspart through recombinant expression by using pichia yeast. Concretely, the method comprises the following technological process: effectively secreting and expressing human aspart proinsulin, performing lysyl endopeptidase single enzyme digestion to obtain insulin aspart deleting B30, coupling with a threoninate, and performing deprotection, anti-phase purification and crystallization. The method is relatively suitable for industrialized preparation of recombinant insulin aspart.

Description

technical field [0001] The invention belongs to the field of preparation of recombinant protein under biotechnology. The invention discloses a preparation method for recombinantly expressing insulin aspart by yeast. Background technique [0002] Diabetes mellitus is a metabolic disorder characterized by hyperglycemia caused by defective insulin secretion or insulin resistance. At present, China has become the country with the largest number of diabetic patients in the world. Diabetes has become the third most harmful disease after cardiovascular and cerebrovascular diseases and tumors. Diabetic patients are often accompanied by a variety of complications, which can easily lead to kidney, eye, heart and blood vessel damage, dysfunction and failure of many organs, which is extremely harmful. [0003] The deviation between the peak of postprandial glucose and the peak arrival time of injected insulin brings difficulties to the application of insulin injection, thus promoting...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12P21/02C07K14/62C12P21/06C12R1/84C12R1/865
Inventor 冯一建范开何勇
Owner CHONGQING PEG BIO BIOTECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products